AETHLON MEDICAL, INC. (AEMD) Free cash flow 2017–2026
AETHLON MEDICAL, INC. (AEMD) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$7.0MFY2026 · since FY2017: -$3.5M → -$7.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$7.0M | +8.4% |
| FY2025 | -$7.6M | +26.3% |
| FY2024 | -$10.4M | +9.3% |
| FY2023 | -$11.4M | -13.2% |
| FY2022 | -$10.1M | -48.2% |
| FY2021 | -$6.8M | -27.6% |
| FY2020 | -$5.3M | -24.6% |
| FY2019 | -$4.3M | -9.1% |
| FY2018 | -$3.9M | -11.7% |
| FY2017 | -$3.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice